HK1044534B - 噠嗪-3-酮衍生物和含有該類化合物的藥物 - Google Patents
噠嗪-3-酮衍生物和含有該類化合物的藥物Info
- Publication number
- HK1044534B HK1044534B HK02106060.0A HK02106060A HK1044534B HK 1044534 B HK1044534 B HK 1044534B HK 02106060 A HK02106060 A HK 02106060A HK 1044534 B HK1044534 B HK 1044534B
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- substituted
- unsubstituted
- pyridazin
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11049758A JP2000247959A (ja) | 1999-02-26 | 1999-02-26 | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
PCT/JP2000/001098 WO2000050408A1 (fr) | 1999-02-26 | 2000-02-25 | Derives de pyridazin-3-one et medicaments contenant ces derives |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1044534A1 HK1044534A1 (en) | 2002-10-25 |
HK1044534B true HK1044534B (zh) | 2004-12-10 |
Family
ID=12840099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02106060.0A HK1044534B (zh) | 1999-02-26 | 2002-08-20 | 噠嗪-3-酮衍生物和含有該類化合物的藥物 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6680316B1 (zh) |
EP (1) | EP1156039B1 (zh) |
JP (2) | JP2000247959A (zh) |
KR (1) | KR100647726B1 (zh) |
CN (1) | CN1148355C (zh) |
AT (1) | ATE305926T1 (zh) |
AU (1) | AU764393B2 (zh) |
CA (1) | CA2364801C (zh) |
DE (1) | DE60022986T2 (zh) |
DK (1) | DK1156039T3 (zh) |
ES (1) | ES2250100T3 (zh) |
HK (1) | HK1044534B (zh) |
HU (1) | HUP0200088A3 (zh) |
NO (1) | NO319832B1 (zh) |
NZ (1) | NZ513578A (zh) |
RU (1) | RU2232755C2 (zh) |
TW (1) | TWI249533B (zh) |
WO (1) | WO2000050408A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2209813C2 (ru) * | 1997-11-19 | 2003-08-10 | Кова Ко., Лтд. | Производные пиридазина, лекарственные средства на их основе и способ лечения артрита |
MXPA03002324A (es) * | 2000-09-18 | 2003-06-06 | Eisai Co Ltd | Compuestos de piridazinona y triazinona y su uso como preparaciones farmaceuticas. |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
WO2003027077A1 (fr) * | 2001-09-26 | 2003-04-03 | Kowa Co., Ltd. | Derives de phenylpyridazine solubles dans l'eau et medicaments contenant ceux-ci |
WO2004078751A1 (ja) * | 2003-03-07 | 2004-09-16 | Kowa Co., Ltd. | ベンゾフラン誘導体 |
WO2004083188A1 (ja) * | 2003-03-18 | 2004-09-30 | Kowa Co., Ltd. | 水溶性フェニルピリダジン誘導体及びこれを含有する医薬 |
EP1628665A2 (en) * | 2003-04-16 | 2006-03-01 | Amgen Inc. | 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations |
WO2007044796A2 (en) * | 2005-10-11 | 2007-04-19 | Nps Pharmaceuticals, Inc. | Pyridazinone compounds as calcilytics |
WO2007049732A1 (ja) * | 2005-10-28 | 2007-05-03 | Kowa Co., Ltd. | 関節リウマチの予防及び/又は治療法 |
PL2953944T3 (pl) * | 2013-02-07 | 2017-09-29 | Merck Patent Gmbh | Pochodne pirydazynonowe-amidowe |
MX2017009624A (es) * | 2015-02-06 | 2017-11-20 | Merck Patent Gmbh | Macrociclos de piridazinona como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. |
FR3103701B1 (fr) * | 2019-11-28 | 2021-11-26 | Inst Nat Sante Rech Med | Composés de typen2-arylméthyl-4-haloalkyl-pyridazin-3-one et leur utilisation |
JP2023513239A (ja) | 2020-02-14 | 2023-03-30 | エフ エム シー コーポレーション | 殺真菌薬としての使用のための置換5,6-ジフェニル-3(2h)-ピリダジノン |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2839532A (en) * | 1958-06-17 | Pyridazone compounds and process of | ||
GB788393A (en) * | 1953-04-30 | 1958-01-02 | Ciba Ltd | Process for the manufacture of pyridazone compounds |
US3840597A (en) | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
AR206496A1 (es) | 1972-07-03 | 1976-07-30 | Riker Laboratories Inc | Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas |
US4238490A (en) * | 1979-02-12 | 1980-12-09 | Diamond Shamrock Corporation | Antihypertensive pyridazin(2H)-3-ones |
US4545810A (en) | 1980-08-07 | 1985-10-08 | Sds Biotech Corporation | Herbicidal and plant growth regulant diphenylpyridazinones |
JPS57501328A (zh) * | 1980-08-07 | 1982-07-29 | ||
JPH0753725B2 (ja) | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
FI91062C (fi) | 1988-12-28 | 1994-05-10 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisten naftaleenijohdannaisten valmistamiseksi |
MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
DE69408598T2 (de) | 1993-06-08 | 1998-09-17 | Vertex Pharmaceuticals Inc Cam | Pyridazine als Interleukin-1-beta Verwandlungsenzym Inhibitoren |
CA2228050A1 (en) | 1995-08-10 | 1997-02-20 | Harold G. Selnick | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
PT1005460E (pt) | 1997-08-22 | 2006-07-31 | Abbott Lab | Biossintese de inibidores de prostaglandina-endoperoxido h-sintase |
WO1999010331A1 (en) | 1997-08-22 | 1999-03-04 | Abbott Laboratories | Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
RU2209813C2 (ru) | 1997-11-19 | 2003-08-10 | Кова Ко., Лтд. | Производные пиридазина, лекарственные средства на их основе и способ лечения артрита |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
ES2249919T3 (es) | 1998-10-27 | 2006-04-01 | Abbott Laboratories | Inhibidores de la biosintesis de prostaglandina endoperoxido h sintasa. |
-
1999
- 1999-02-26 JP JP11049758A patent/JP2000247959A/ja active Pending
-
2000
- 2000-02-25 NZ NZ513578A patent/NZ513578A/en not_active Application Discontinuation
- 2000-02-25 CA CA002364801A patent/CA2364801C/en not_active Expired - Fee Related
- 2000-02-25 DE DE60022986T patent/DE60022986T2/de not_active Expired - Lifetime
- 2000-02-25 DK DK00905344T patent/DK1156039T3/da active
- 2000-02-25 WO PCT/JP2000/001098 patent/WO2000050408A1/ja active IP Right Grant
- 2000-02-25 EP EP00905344A patent/EP1156039B1/en not_active Expired - Lifetime
- 2000-02-25 CN CNB00804242XA patent/CN1148355C/zh not_active Expired - Fee Related
- 2000-02-25 AU AU26928/00A patent/AU764393B2/en not_active Ceased
- 2000-02-25 HU HU0200088A patent/HUP0200088A3/hu unknown
- 2000-02-25 JP JP2000600991A patent/JP4456765B2/ja not_active Expired - Fee Related
- 2000-02-25 KR KR1020017009829A patent/KR100647726B1/ko not_active IP Right Cessation
- 2000-02-25 TW TW089103388A patent/TWI249533B/zh not_active IP Right Cessation
- 2000-02-25 AT AT00905344T patent/ATE305926T1/de not_active IP Right Cessation
- 2000-02-25 RU RU2001126063/04A patent/RU2232755C2/ru active
- 2000-02-25 ES ES00905344T patent/ES2250100T3/es not_active Expired - Lifetime
- 2000-02-25 US US09/926,040 patent/US6680316B1/en not_active Expired - Fee Related
-
2001
- 2001-08-23 NO NO20014099A patent/NO319832B1/no not_active IP Right Cessation
-
2002
- 2002-08-20 HK HK02106060.0A patent/HK1044534B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2364801A1 (en) | 2000-08-31 |
DE60022986T2 (de) | 2006-05-11 |
RU2232755C2 (ru) | 2004-07-20 |
EP1156039A4 (en) | 2002-04-17 |
WO2000050408A1 (fr) | 2000-08-31 |
JP2000247959A (ja) | 2000-09-12 |
DE60022986D1 (de) | 2006-02-16 |
TWI249533B (en) | 2006-02-21 |
KR100647726B1 (ko) | 2006-11-23 |
CN1148355C (zh) | 2004-05-05 |
NO319832B1 (no) | 2005-09-19 |
DK1156039T3 (da) | 2006-01-30 |
NZ513578A (en) | 2005-04-29 |
ATE305926T1 (de) | 2005-10-15 |
CA2364801C (en) | 2009-05-19 |
EP1156039B1 (en) | 2005-10-05 |
HK1044534A1 (en) | 2002-10-25 |
NO20014099D0 (no) | 2001-08-23 |
AU764393B2 (en) | 2003-08-14 |
US6680316B1 (en) | 2004-01-20 |
EP1156039A1 (en) | 2001-11-21 |
KR20010101979A (ko) | 2001-11-15 |
CN1341103A (zh) | 2002-03-20 |
NO20014099L (no) | 2001-10-23 |
AU2692800A (en) | 2000-09-14 |
HUP0200088A2 (hu) | 2002-11-28 |
JP4456765B2 (ja) | 2010-04-28 |
HUP0200088A3 (en) | 2002-12-28 |
ES2250100T3 (es) | 2006-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR987000261A (ko) | 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide) | |
DK0598359T3 (da) | Hypoglykæmiske dihydrochalconderivater | |
HK1044534A1 (en) | Pyridazin-3-one derivatives and medicines containing the same. | |
EP1134214A4 (en) | PICOLINAMIDE DERIVATIVES AND PESTICIDES CONTAINING THESE DERIVATIVES AS ACTIVE INGREDIENT | |
EP1300399A4 (en) | PHENYLPYRIDAZINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM | |
IE821337L (en) | Mandelic acid derivatives and mandelonitriles. | |
IL114875A (en) | Quinolone or naphthylidone-carboxylic acid derivatives or their salts and pharmaceutical compositions containing them | |
DE69935718D1 (de) | Antidiabetische medikamente | |
CA2126465A1 (en) | Inhibitor for restenosis after percutaneous coronary arterioplasty | |
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
HUT63598A (en) | Process for producing phenyl cycloalkyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
DE60117847D1 (de) | Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate | |
NO903335L (no) | Substituerte aminoalkoksy-benzolderivater. | |
EP1130015A4 (en) | PYRIDAZINONE DERIVATIVES | |
WO1998006400A3 (en) | Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells | |
AU2318600A (en) | Chondrongenesis promotors and indolin-2-one derivatives | |
AU699392B2 (en) | Triazine derivatives | |
EP1319658A4 (en) | IMIDAZOLE DERIVATIVES OR THEIR SALTS | |
JPS57197218A (en) | Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative | |
EP0418655A3 (en) | Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient | |
AU6730600A (en) | Vitamin d derivatives having substituents at the 2alpha-position | |
JPS6429301A (en) | Bactericidal fungicidal compound composition | |
EG20464A (en) | Amidothiophosphate derivative and insecticide nematocide acaricide containing the same as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100225 |